Cardurion Pharmaceuticals

About:

Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.

Website: http://cardurion.com

Top Investors: Blue Owl, Fidelity, Takeda, Invus, New Enterprise Associates

Description:

Cardurion Pharmaceuticals is a Boston-based biotechnology company focused on developing novel therapeutics for the treatment of heart failure and other cardiovascular diseases. The company is advancing groundbreaking clinical programs targeting PDE9 and CaMKII inhibition, leveraging its expertise in cardiovascular signaling pathways to address unmet patient needs.